MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are small non-protein-coding RNAs that function as negative gene expression regulators. In the present study, we investigated miRNAs role in endothelial cell response to hypoxia. We found that the expression of miR-210 progressively increased upon exposure to hypoxia. miR-210 overexpression in normoxic endothelial cells stimulated the formation of capillary-like structures on Matrigel and vascular endothelial growth factor-driven cell migration. Conversely, miR-210 blockade via anti-miRNA transfection inhibited the formation of capillary-like structures stimulated by hypoxia and decreased cell migration in response to vascular endothelial growth factor. miR-210 overexpression did not affect endothelial cell growth in both normoxia and hypoxia. However, anti-miR-210 transfection inhibited cell growth and induced apoptosis, in both normoxia and hypoxia. We determined that one relevant target of miR-210 in hypoxia was Ephrin-A3 since miR-210 was necessary and sufficient to down-modulate its expression. Moreover, luciferase reporter assays showed that Ephrin-A3 was a direct target of miR-210. Ephrin-A3 modulation by miR-210 had significant functional consequences; indeed, the expression of an Ephrin-A3 allele that is not targeted by miR-210 prevented miR-210-mediated stimulation of both tubulogenesis and chemotaxis. We conclude that miR-210 up-regulation is a crucial element of endothelial cell response to hypoxia, affecting cell survival, migration, and differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“hypoxia-induced miR-210 in endothelial cells has been shown to promote angiogenesis by targeting Ephrin-A3 (EFNA3) [233].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [233]
Experimental — accuracy not yet measuredIn the citing paper
“Studies have reported that miR‐210 is a highly upregulated miRNA in hypoxic cells and may serve as an in vivo marker of tumor hypoxia. 405 , 406”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [406]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & Steitz, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,822
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Ribo-gnome: The Big World of Small RNAs
Zamore, P. D., & Haley, B. (2005) · Science · doi:10.1126/science.1111444 · Cited by 1,288
Kubota, Y., Kleinman, H. K., Martin, G. R., & Lawley, T. J. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1589 · Cited by 1,209
(2005) · doi:10.1093/nar/gki200 · Cited by 1,208
Research works printed but not linked: 2
- Livak, K. J., and Schmittgen, T. D. (2001) Methods (Amst.) 25, 402-408
- Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto- Perez, F. J., Davuluri, R., Liu, C. G., Croce, C. M., Negrini, M., Calin, G. A., and Ivan, M. (2006) Mol. Cell. Biol. 28, 28
Cited by
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
The role of MicroRNAs in human cancer
Peng, Y., & Croce, C. M. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.4 · Cited by 2,483
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Di Leva, G., Garofalo, M., & Croce, C. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,672
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,305
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Hypoxia-Induced Angiogenesis: Good and Evil
Krock, B. L., Skuli, N., & Simon, M. C. (2011) · Genes & Cancer · doi:10.1177/1947601911423654 · Cited by 1,180
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Hypoxic enhancement of exosome release by breast cancer cells
King, H. W., Michael, M. Z., & Gleadle, J. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-421 · Cited by 1,045
“This could play a role in promoting tumour progression in response to hypoxia, as miR-210 can promote endothelial cell tubulogenesis [52], as well as repressing DNA repair pathways [53].”
BackgroundHypoxia signalling through mTOR and the unfolded protein response in cancer
Wouters, B. G., & Koritzinsky, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2501 · Cited by 894
Role of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880
“MiR-210 overexpression enhanced the formation of capillary-like structures and VEGF-driven migration of normoxic endothelial cells, whereas inhibition of miR-210 decreased tube formation and migration.(38) The modulation of endothelial cell responses to hypoxia is mediated via the regulation of the receptor tyrosine-k…”
BackgroundAdvances in Hypoxia-Inducible Factor Biology
Choudhry, H., & Harris, A. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.005 · Cited by 868
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
D'Alessandra, Y., Devanna, P., Limana, F., Straino, S., Di Carlo, A., Brambilla, P. G., Rubino, M., Carena, M. C., Spazzafumo, L., De Simone, M., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq167 · Cited by 797
Self-citationKosaka, N., Iguchi, H., Hagiwara, K., Yoshioka, Y., Takeshita, F., & Ochiya, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446831 · Cited by 771
Non-coding RNAs as regulators of gene expression and epigenetics
Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr097 · Cited by 764
Barile, L., Lionetti, V., Cervio, E., Matteucci, M., Gherghiceanu, M., Popescu, L. M., Torre, T., Siclari, F., Moccetti, T., & Vassalli, G. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu167 · Cited by 732
Chan, S. Y., Zhang, Y.-Y., Hemann, C., Mahoney, C. E., Zweier, J. L., & Loscalzo, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.015 · Cited by 702
“Some, but not all, of these miRNA have been identified in other transformed (Kulshreshtha et al., 2007) or primary endothelial cells (Fasanaro et al., 2008) exposed to hypoxia.”
InfluentialDefining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629
Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation
Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., Story, M., Le, Q.-T., & Giaccia, A. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.006 · Cited by 617
MicroRNAs Add a New Dimension to Cardiovascular Disease
Small, E. M., Frost, R. J. A., & Olson, E. N. (2010) · Circulation · doi:10.1161/circulationaha.109.889048 · Cited by 599
The Role of MicroRNAs in Human Diseases.
Ardekani, A. M., & Naeini, M. M. (2010) · PubMed Central · Cited by 727
MicroRNAome genome: A treasure for cancer diagnosis and therapy
Berindan‐Neagoe, I., Monroig, P. D. C., Pasculli, B., & Calin, G. A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21244 · Cited by 522
MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
Hu, S., Huang, M., Li, Z., Jia, F., Ghosh, Z., Lijkwan, M. A., Fasanaro, P., Sun, N., Wang, X., Martelli, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.928424 · Cited by 462
Self-citationGreither, T., Grochola, L. F., Udelnow, A., Lautenschläger, C., Würl, P., & Taubert, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.24687 · Cited by 448
AngiomiRs—Key regulators of angiogenesis
Wang, S., & Olson, E. N. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.002 · Cited by 450
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Tirpe, A. A., Gulei, D., Ciortea, S. M., Crivii, C., & Berindan-Neagoe, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246140 · Cited by 438
MicroRNA regulation of DNA repair gene expression in hypoxic stress
Crosby, M. E., Kulshreshtha, R., Ivan, M., & Glazer, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2516 · Cited by 437
“The ability of such synthetic RNA-based anti-miRs to block miRNA activity has been established in prior studies (38).”
BackgroundBaggish, A. L., Hale, A., Weiner, R. B., Lewis, G. D., Systrom, D., Wang, F., Wang, T. J., & Chan, S. Y. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.213363 · Cited by 431
Puisségur, M.-P., Mazure, N. M., Bertero, T., Pradelli, L., Grosso, S., Robbe-Sermesant, K., Maurin, T., Lebrigand, K., Cardinaud, B., Hofman, V, et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.119 · Cited by 423
Ghosh, G., Subramanian, I. V., Adhikari, N., Zhang, X., Joshi, H. P., Basi, D., Chandrashekhar, Y. S., Hall, J. L., Roy, S., Zeng, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42980 · Cited by 420
MicroRNAs As Novel Regulators of Angiogenesis
Suárez, Y., & Sessa, W. C. (2009) · Circulation Research · doi:10.1161/circresaha.108.191270 · Cited by 416
Regulation of Angiogenesis by Oxygen and Metabolism
Fraisl, P., Mazzone, M., Schmidt, T., & Carmeliet, P. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.003 · Cited by 413
Tumour angiogenesis regulation by the miR-200 family
Pecot, C. V., Rupaimoole, R., Yang, D., Akbani, R., Ivan, C., Lu, C., Wu, S., Han, H.-D., Shah, M. Y., Rodriguez-Aguayo, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3427 · Cited by 402
MiR-210 – micromanager of the hypoxia pathway
Huang, X., Le, Q.-T., & Giaccia, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.004 · Cited by 376
Won Kim, H., Haider, H. K., Jiang, S., & Ashraf, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020925 · Cited by 370
MicroRNAs in myocardial infarction
Boon, R. A., & Dimmeler, S. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.207 · Cited by 369
CHAN, Y. C., BANERJEE, J., CHOI, S. Y., & SEN, C. K. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2011.00154.x · Cited by 364
Exosomes Derived from Hypoxic Leukemia Cells Enhance Tube Formation in Endothelial Cells
Tadokoro, H., Umezu, T., Ohyashiki, K., Hirano, T., & Ohyashiki, J. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.480822 · Cited by 361
MicroRNA-210: A unique and pleiotropic hypoxamir
Chan, S. Y., & Loscalzo, J. (2010) · Cell Cycle · doi:10.4161/cc.9.6.11006 · Cited by 357
Malzkorn, B., Wolter, M., Liesenberg, F., Grzendowski, M., Stühler, K., Meyer, H. E., & Reifenberger, G. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00328.x · Cited by 352
“In endothelial cells, inhibition of miR-210 reduced cell growth, induced apoptosis and inhibited the formation of capillary-like structures stimulated by hypoxia (12).”
BackgroundVersatile roles of extracellular vesicles in cancer
Kosaka, N., Yoshioka, Y., Fujita, Y., & Ochiya, T. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81130 · Cited by 348
Zhu, X.-M., Han, T., Sargent, I. L., Yin, G.-W., & Yao, Y.-Q. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.12.045 · Cited by 345
MicroRNA and cancer – focus on apoptosis
Wang, Y., & Lee, C. G. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00510.x · Cited by 330
Therapeutic potential of microRNA in tendon injuries
Giordano, L., Porta, G. D., Peretti, G. M., & Maffulli, N. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa002 · Cited by 329
Favaro, E., Ramachandran, A., McCormick, R., Gee, H., Blancher, C., Crosby, M., Devlin, C., Blick, C., Buffa, F., Li, J.-L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010345 · Cited by 324
“Derived only from sequence-based algorithms, some of the previously validated targets of miR-210 include Ephrin A3 [15], E2F3 [16], RAD52 [17], CASP8AP2 [18], and MNT [19].”
BackgroundPathophysiological implications of hypoxia in human diseases
Chen, P.-S., Chiu, W.-T., Hsu, P.-L., Lin, S.-C., Peng, I.-C., Wang, C.-Y., & Tsai, S.-J. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00658-7 · Cited by 318
Dysregulation of microRNAs in cancer: Playing with fire
Melo, S. A., & Esteller, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.08.009 · Cited by 315
Liu, C.-J., Tsai, M.-M., Hung, P.-S., Kao, S.-Y., Liu, T.-Y., Wu, K.-J., Chiou, S.-H., Lin, S.-C., & Chang, K.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2291 · Cited by 303
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018) · Angiogenesis · doi:10.1007/s10456-018-9600-2 · Cited by 288
MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia
Bruning, U., Cerone, L., Neufeld, Z., Fitzpatrick, S. F., Cheong, A., Scholz, C. C., Simpson, D. A., Leonard, M. O., Tambuwala, M. M., Cummins, E. P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01276-10 · Cited by 289
miR‐210: More than a silent player in hypoxia
Devlin, C., Greco, S., Martelli, F., & Ivan, M. (2011) · IUBMB Life · doi:10.1002/iub.427 · Cited by 289
Self-citationWang, X., Qian, R., Zhang, W., Chen, S., Jin, H., & Hu, R. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05057.x · Cited by 271
Mayor-Lynn, K., Toloubeydokhti, T., Cruz, A. C., & Chegini, N. (2011) · Reproductive Sciences · doi:10.1177/1933719110374115 · Cited by 271
van Solingen, C., Seghers, L., Bijkerk, R., Duijs, J. M. G. J., Roeten, M. K., van Oeveren‐Rietdijk, A. M., Baelde, H. J., Monge, M., Vos, J. B., de Boer, H. C., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00613.x · Cited by 269
An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210
Fasanaro, P., Greco, S., Lorenzi, M., Pescatori, M., Brioschi, M., Kulshreshtha, R., Banfi, C., Stubbs, A., Calin, G. A., Ivan, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.052779 · Cited by 268
Self-citationRegulation of gene expression by hypoxia
Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20081055 · Cited by 267
Wang, N., Chen, C., Yang, D., Liao, Q., Luo, H., Wang, X., Zhou, F., Yang, X., Yang, J., Zeng, C., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.023 · Cited by 266
Zhu, J., Lu, K., Zhang, N., Zhao, Y., Ma, Q., Shen, J., Lin, Y., Xiang, P., Tang, Y., Hu, X., et al. (2017) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2017.1388249 · Cited by 264
MicroRNA in ischemic stroke etiology and pathology
Rink, C., & Khanna, S. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00158.2010 · Cited by 255
Greco, S., De Simone, M., Colussi, C., Zaccagnini, G., Fasanaro, P., Pescatori, M., Cardani, R., Perbellini, R., Isaia, E., Sale, P., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-128579 · Cited by 253
Self-citationhsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
Gee, H. E., Camps, C., Buffa, F. M., Patiar, S., Winter, S. C., Betts, G., Homer, J., Corbridge, R., Cox, G., West, C. M. L., et al. (2010) · Cancer · doi:10.1002/cncr.25009 · Cited by 248
MicroRNAs in Vascular and Metabolic Disease
Zampetaki, A., & Mayr, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.247445 · Cited by 244
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M., Araujo, A., Araiz, M., Fernandez-Mercado, M., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050627 · Cited by 239
Placental microRNA expression in pregnancies complicated by preeclampsia
Enquobahrie, D. A., Abetew, D. F., Sorensen, T. K., Willoughby, D., Chidambaram, K., & Williams, M. A. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.09.004 · Cited by 239
Chan, Y. C., Khanna, S., Roy, S., & Sen, C. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158790 · Cited by 237
Zhang, Y., Fei, M., Xue, G., Zhou, Q., Jia, Y., Li, L., Xin, H., & Sun, S. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01291.x · Cited by 236
MicroRNAs and cancer—new paradigms in molecular oncology
Negrini, M., Nicoloso, M. S., & Calin, G. A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.03.002 · Cited by 236
MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
Greco, S., Fasanaro, P., Castelvecchio, S., D’Alessandra, Y., Arcelli, D., Di Donato, M., Malavazos, A., Capogrossi, M. C., Menicanti, L., & Martelli, F. (2012) · Diabetes · doi:10.2337/db11-0952 · Cited by 234
Self-citationMacro view of microRNA function in osteoarthritis
Miyaki, S., & Asahara, H. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.128 · Cited by 233
MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A
Urbich, C., Kaluza, D., Frömel, T., Knau, A., Bennewitz, K., Boon, R. A., Bonauer, A., Doebele, C., Boeckel, J.-N., Hergenreider, E., et al. (2012) · Blood · doi:10.1182/blood-2011-08-373886 · Cited by 231
Jung, M., Mollenkopf, H., Grimm, C., Wagner, I., Albrecht, M., Waller, T., Pilarsky, C., Johannsen, M., Stephan, C., Lehrach, H., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00705.x · Cited by 229
Cellular and molecular mechanisms of endothelial dysfunction in diabetes
Roberts, A. C., & Porter, K. E. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113500680 · Cited by 225
Stability of miRNA in Human Urine Supports its Biomarker Potential
Mall, C., Rocke, D. M., Durbin-Johnson, B., & Weiss, R. H. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.44 · Cited by 224
Kelly, T. J., Souza, A. L., Clish, C. B., & Puigserver, P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01242-10 · Cited by 218
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
Grosso, S., Doyen, J., Parks, S. K., Bertero, T., Paye, A., Cardinaud, B., Gounon, P., Lacas-Gervais, S., Noël, A., Pouysségur, J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.71 · Cited by 216
Sarkar, J., Gou, D., Turaka, P., Viktorova, E., Ramchandran, R., & Raj, J. U. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00201.2010 · Cited by 216
“From recent reports on hypoxia-regulated miRNAs (7, 14, 18, 20, 29, 32-34), miR-210 has been identified as being the most upregulated in hypoxia.”
BackgroundChow, T.-F. F., Youssef, Y. M., Lianidou, E., Romaschin, A. D., Honey, R. J., Stewart, R., Pace, K. T., & Yousef, G. M. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.07.020 · Cited by 214
Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans
Li, T., Cao, H., Zhuang, J., Wan, J., Guan, M., Yu, B., Li, X., & Zhang, W. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.029 · Cited by 213
Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria
Thomas, L. W., & Ashcroft, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03039-y · Cited by 213
MicroRNA-26a Regulates Pathological and Physiological Angiogenesis by Targeting BMP/SMAD1 Signaling
Icli, B., Wara, A. K. M., Moslehi, J., Sun, X., Plovie, E., Cahill, M., Marchini, J. F., Schissler, A., Padera, R. F., Shi, J., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301780 · Cited by 211
Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells
Cardinali, B., Castellani, L., Fasanaro, P., Basso, A., Alemà, S., Martelli, F., & Falcone, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007607 · Cited by 208
Self-citation(2017) · Anticancer Research · doi:10.21873/anticanres.12107 · Cited by 210
Dentelli, P., Rosso, A., Orso, F., Olgasi, C., Taverna, D., & Brizzi, M. F. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.206201 · Cited by 206
Circulating miR-210 Predicts Survival in Critically Ill Patients with Acute Kidney Injury
Lorenzen, J. M., Kielstein, J. T., Hafer, C., Gupta, S. K., Kümpers, P., Faulhaber-Walter, R., Haller, H., Fliser, D., & Thum, T. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00430111 · Cited by 204
Moghaddam, A. S., Afshari, J. T., Esmaeili, S.-A., Saburi, E., Joneidi, Z., & Momtazi-Borojeni, A. A. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.03.016 · Cited by 202
Urinary miR-210 as a Mediator of Acute T-Cell Mediated Rejection in Renal Allograft Recipients
Lorenzen, J. M., Volkmann, I., Fiedler, J., Schmidt, M., Scheffner, I., Haller, H., Gwinner, W., & Thum, T. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03679.x · Cited by 200
miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia
Lou, Y.-L., Guo, F., Liu, F., Gao, F.-L., Zhang, P.-Q., Niu, X., Guo, S.-C., Yin, J.-H., Wang, Y., & Deng, Z.-F. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1396-6 · Cited by 200
Cellular and molecular mechanisms of inflammation‐induced angiogenesis
Szade, A., Grochot‐Przeczek, A., Florczyk, U., Jozkowicz, A., & Dulak, J. (2015) · IUBMB Life · doi:10.1002/iub.1358 · Cited by 199
From Inflammation to Current and Alternative Therapies Involved in Wound Healing
Serra, M. B., Barroso, W. A., Silva, N. N. D., Silva, S. D. N., Borges, A. C. R., Abreu, I. C., & Borges, M. O. D. R. (2017) · International Journal of Inflammation · doi:10.1155/2017/3406215 · Cited by 198
Gestational Hypoxia and Developmental Plasticity
Ducsay, C. A., Goyal, R., Pearce, W. J., Wilson, S., Hu, X.-Q., & Zhang, L. (2018) · Physiological Reviews · doi:10.1152/physrev.00043.2017 · Cited by 198
Oxidative Stress and MicroRNAs in Vascular Diseases
Magenta, A., Greco, S., Gaetano, C., & Martelli, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917319 · Cited by 196
Self-citationMicroRNAs and Their Target Genes in Gingival Tissues
Stoecklin-Wasmer, C., Guarnieri, P., Celenti, R., Demmer, R. T., Kebschull, M., & Papapanou, P. N. (2012) · Journal of Dental Research · doi:10.1177/0022034512456551 · Cited by 195
Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress
Farías, J., Molina, V., Carrasco, R., Zepeda, A., Figueroa, E., Letelier, P., & Castillo, R. (2017) · Nutrients · doi:10.3390/nu9090966 · Cited by 194
Hypoxia response and microRNAs: no longer two separate worlds
Ivan, M., Harris, A. L., Martelli, F., & Kulshreshtha, R. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00398.x · Cited by 193
Self-citationHantavirus regulation of endothelial cell functions
Gavrilovskaya, I., & Mackow, E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-09-0640 · Cited by 191
The Role of Epigenetics in Placental Development and the Etiology of Preeclampsia
Apicella, C., Ruano, C. S. M., Méhats, C., Miralles, F., & Vaiman, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112837 · Cited by 190
Cui, H., Seubert, B., Stahl, E., Dietz, H., Reuning, U., Moreno-Leon, L., Ilie, M., Hofman, P., Nagase, H., Mari, B., et al. (2015) · Oncogene · doi:10.1038/onc.2014.300 · Cited by 190
miRNAs as Modulators of Angiogenesis
Landskroner-Eiger, S., Moneke, I., & Sessa, W. C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006643 · Cited by 190
Hypoxia-Inducible miR-210 Regulates the Susceptibility of Tumor Cells to Lysis by Cytotoxic T Cells
Noman, M. Z., Buart, S., Romero, P., Ketari, S., Janji, B., Mari, B., Mami-Chouaib, F., & Chouaib, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1383 · Cited by 188
“miR-210 is also generally recognized as a robust HIF1 target (16, 28) and an in vivo marker of tumor hypoxia (29, 30).”
MicroRNAs: molecular features and role in cancer
Lages, E. (2012) · Frontiers in Bioscience · doi:10.2741/4068 · Cited by 187
Metadata
- Authors
- Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F.
- Affiliations
- Istituto Dermopatico dell'Immacolata (IT)
- Centro Cardiologico Monzino (IT)
- Corresponding author
- Martelli, Fabio
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 283
- Issue
- 23
- Pages
- 15878-15883
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC3259646
- OpenAlex
- W2139128338
- Cited by
- 912
- References
- 28
- Citations by year
- 2026: 21 · 2025: 28 · 2024: 39 · 2023: 38 · 2022: 32 · 2021: 43 · 2020: 54 · 2019: 48 · 2018: 52 · 2017: 65 · 2016: 53 · 2015: 54 · 2014: 72 · 2013: 82 · 2012: 80
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4488 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministero della Salute (RF06-Conv.74.1, RF07Onc-26/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- miR-210, hypoxia, endothelial cells, ephrin-A3, receptor tyrosine kinase, angiogenesis, vascular endothelial growth factor, cell migration, apoptosis, cell survival, chemotaxis, microRNA target regulation
- MeSH terms
- Cell Differentiation, Cell Survival, Cells, Cultured, Chemotaxis, Gene Expression Regulation, Humans, Transfection, Cell Hypoxia, RNA, Antisense, Apoptosis, MicroRNAs, Ephrin-A3, Vascular Endothelial Growth Factor A, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.